QuadMedicine, Inc. (KOSDAQ:464490)

Market Cap	131.13B
Revenue (ttm)	10.70B +15.0%
Net Income	-6.93B
EPS	-722.00
Shares Out	11.48M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	148,373
Average Volume	129,355
Open	11,270
Previous Close	11,440
Day's Range	10,730 - 11,640
52-Week Range	10,730 - 27,150
Beta	n/a
RSI	28.64
Earnings Date	May 14, 2026

About QuadMedicine

QuadMedicine, Inc. engages in research, development, and production of healthcare vaccination needles based on the microneedle array patch (MAP). The company develops vaccinations for children living in remote areas to protect them from infectious diseases, such as diphtheria, tetanus, polio, measles, and hepatitis B. The company focuses on technology integration for medical and pharmaceutical microneedle development. It also provides fundamental MAP research through prototyping to MAP production for clinical trials. The company was incorporate...

• Industry: Biological Products, Except Diagnostic Substances
• Founded: 2016
• Country: South Korea
• Stock Exchange: KOSDAQ
• Ticker Symbol: 464490

Financial Performance

In 2025, QuadMedicine's revenue was 10.70 billion, an increase of 14.99% compared to the previous year's 9.30 billion. Losses were -6.93 billion, 39.5% more than in 2024.